- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04302740
Life Enhancing Alcohol-management Program (LEAP)
A Cluster-randomized Controlled Trial Testing the Effectiveness of the Life Enhancing Alcohol-management Program (LEAP) for Housing First Residents
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Although they represent only 15% of the larger homeless population, chronically homeless people utilize substantially more services. This finding is understandable given that chronic homelessness is characterized by long or frequent episodes of homelessness paired with medical, psychiatric, and substance use disorders. Although epidemiologic data for chronically homeless people are scarce, studies conducted with the larger homeless population indicate that 80% of homeless people report current alcohol use, and 38% have severe alcohol use disorders (AUDs). This disproportionately problematic use results in alcohol-attributable mortality that is 6 to 10 times higher than in the general US population. Alcohol-related harm impacts the affected individual; however, it also has secondhand effects on the larger community as well, including caretaking burden, noise complaints, verbal altercations, and physical and sexual assault.
Unfortunately, the most widely available approach-individual-level, abstinence-based treatment-does not effectively engage or treat this population. In our prior research, chronically homeless people with AUDs indicated they were not interested in abstinence-based approaches, having experienced a mean of 16 abstinence-based treatment episodes in their lifetimes. Further, our research has shown that improvements in alcohol outcomes in this population are associated with intrinsic motivation for change but not with abstinence-based treatment attendance. Instead, chronically homeless people with AUDs have indicated that they prefer community-based, harm-reduction approaches that support their own self-defined pathways to recovery. They are particularly interested in creative and socially engaging activities that bear personal meaning.
As applied to alcohol use, harm reduction refers to a broad range of compassionate and pragmatic approaches applied at the individual, community, population or policy levels that aim to reduce alcohol-related harm and improve quality of life (QoL) for affected people and their communities. Housing First, also referred to as harm-reduction housing, is one such approach. Housing First entails the provision of immediate, permanent, low-barrier, supportive housing without preconditions such as alcohol abstinence or treatment attendance. Our own and others' research has shown Housing First to be associated with reductions in alcohol-related harm as well as publicly funded service utilization and cost (e.g., emergency medical services, emergency department, jail) for people experiencing chronic homelessness. Despite these positive outcomes, many Housing First residents still experience alcohol-related harm due to their own and their neighbors' alcohol use. There is thus a need for further interventions to address alcohol use in this setting.
In response to this need, our research team used a community-based participatory research approach to work together with Housing First residents, management and staff to develop and initially test the effectiveness of a community-level intervention, the Life Enhancing Alcohol-management Program (LEAP) to improve alcohol and quality-of-life (QoL) outcomes for residents living in Housing First settings (K01AA021147; PI: Clifasefi). We first conducted needs assessments with residents, staff, and management and then formed a community advisory board to oversee the development, implementation, and evaluation of the LEAP. Together, we developed LEAP values, processes, and components. LEAP components for residents included leadership opportunities, LEAP activities, and pathways to recovery. Once developed, the LEAP was tested in a nonrandomized controlled pilot (N=116) with residents at 3 Housing First sites: 2 sites served as services-as-usual control sites and 1 received LEAP. Findings were promising: LEAP participants reported significantly more engagement in meaningful activities than control participants. This finding is important because engagement in meaningful activities is associated with improved medical, psychiatric, and substance-use outcomes. In within-subjects analyses, LEAP participants showed significant pre-post reductions in alcohol use and alcohol-related problems. These changes showed a dose-response effect based on participants' attendance at LEAP activities: high levels of LEAP programming engagement (>2 activities per month) predicted significant reductions in alcohol quantity and alcohol-related harm (ps < .01).
To establish a more definitive evidence base for LEAP, we propose to test LEAP effectiveness using a 2-arm, 12-month, cluster-randomized controlled trial at 10 Housing First sites (N=160). Sites will be randomized to the services-as-usual control or LEAP conditions. Quantitative analyses will test LEAP effectiveness in improving participants' alcohol and QoL outcomes from baseline through the 3, 6-, and 12-month follow-up assessments.
The specific aims are to test:
- LEAP effectiveness in reducing alcohol use and alcohol-related harm and improving QoL. Compared to controls, LEAP participants will report less alcohol use; less first- and secondhand alcohol-related harm; and improved health-related and general QoL over the follow-up.
Group differences in participants' engagement in meaningful activities as well as its role as a mediator of changes on alcohol and QoL outcomes.
- Over time, it is expected that LEAP participants will report more engagement in meaningful activities than control participants.
- It is expected that greater engagement in meaningful activities will explain the hypothesized positive LEAP effect on outcomes.
- LEAP effects on costs associated with healthcare and criminal justice service utilization (i.e., emergency medical services, emergency department services, jail). Compared to control participants, LEAP participants will show greater decreases in service utilization costs over time.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98104
- University of Washington - Harborview Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- At-risk drinking as established by the AUDIT-C at screening (cut-off scores: men > = 3, women > = 2
- Having a history of chronic homelessness according to the widely accepted federal definition (i.e., having a psychiatric, medical, or substance use disorder paired with being homeless for a year or more or having 4 or more episodes of homelessness in the past 3 years)
- Being a current DESC client living in 1 of 10 participating Housing First sites
Exclusion Criteria:
- Refusal or inability to consent to participation in research
- Constituting a risk to the safety and security of other clients or staff
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: LEAP
Housing First plus LEAP
|
The LEAP is a comprehensive, multidimensional, community-level intervention offered in Housing First settings that was developed using a CBPR framework.
The LEAP principles, process, and components were conceptualized and operationalized by the CAB in the pilot study, and are outlined in a recently published articles in the American Psychologist and Journal of Community Psychology.
Briefly, LEAP principles include recognizing and respecting community as a key unit of identity versus solely as individuals in a traditional research hierarchy; embracing cultural humility; practicing pragmatism and compassion; aiming to build equitable research partnerships with communities; acknowledging and promoting community strengths; and supporting relevant, sustainable, positive and community-led change.
|
No Intervention: Service-As-Usual
Housing First
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcohol and Substance-use Frequency Assessment
Time Frame: Change across the 12 month follow up
|
The Alcohol and Substance-use Frequency Assessment questions were adapted from the Addiction Severity Index (McLellan, Kushner, Metzger, & Peters, 1992) and will be used to assess frequency of use of alcohol and other substance use
|
Change across the 12 month follow up
|
The Alcohol Quantity and Use Assessment (AQUA)
Time Frame: Change across the 12-month follow-up
|
The Alcohol Quantity and Use Assessment (AQUA) was created by the research team for previous studies with a similar population and will be used to record the quantity of alcohol consumed on participants' heaviest, typical, and lightest drinking days in the past month.
Scores are expressed in number of standard drinks with higher numbers indicating heavier drinking.
|
Change across the 12-month follow-up
|
Firsthand Alcohol-Related Harms
Time Frame: Change across the 12-month follow-up
|
The Short Inventory of Problems (SIP-2R) is a psychometrically reliable and valid, 15-item, Likert-scale questionnaire that measures experience with social, occupational, and psychological harms related to one's own alcohol use.
Scores range from 0 to 45 with higher scores indicating more severe alcohol-related harm.
|
Change across the 12-month follow-up
|
Secondhand Alcohol-Related Harms
Time Frame: Change across the 12-month follow-up
|
Secondhand effects of alcohol will be measured using a newly developed, psychometrically sound questionnaire, augmented by items from prior validated surveys.
The 8, dichotomous items include feeling unsafe; being harassed, bothered, called names or insulted; being pushed, hit or assaulted; having one's living space disturbed; having one's property stolen or damaged; experiencing unwanted sexual advances; having to take care of another resident who drank too much; and having sleep or other activities interrupted.
The summary score will be used to reflect overall experience of secondhand alcohol-related harm as an outcome variable.
Scores range from 0 to 30 with higher scores indicating more severe secondhand alcohol-related harm.
|
Change across the 12-month follow-up
|
EtG Presence
Time Frame: Change across the 12-month follow-up
|
Presence of EtG, a direct metabolite of alcohol (cut-off > 500 ng/ml), which is indicative of heavy alcohol use within the past 3 days, will be used as a primary outcome.
|
Change across the 12-month follow-up
|
Costs associated with healthcare and criminal justice service utilization
Time Frame: 6 months prior to baseline through 12-month follow-up
|
We will collect administrative data from local county and state databases reflecting participants' utilization of emergency medical services, hospital, and jail and associated cost estimates.
These data will be summed across types to create overall cost outcomes, which will serve as the primary outcome for specific aim 3.
|
6 months prior to baseline through 12-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health-Related Quality of Life
Time Frame: Change across the 12-month follow-up
|
The EuroQoL-5D-5L self-report measure yields 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Additionally, the EQ-Visual Analog Scale (EQ-VAS) is a single item representing health-related quality of life via participants' general assessments of their current health, where 0 = the worst health imaginable and 100 = the best health imaginable.
|
Change across the 12-month follow-up
|
General Quality of Life
Time Frame: Change across the 12-month follow-up
|
The Quality of Life Scale (QOLS) elicits subjective assessments of general QoL across various domains (i.e., material and physical well-being; relationships; social, community, and civic activities; personal development and fulfilment; and recreation).
Scores range from 16 to 112 where a higher score indicates higher quality of life.
The QOLS is reliable and valid across various patient groups and cultures and is conceptually distinct from measures of health-related QoL, such as the EQ-5D-5L.
|
Change across the 12-month follow-up
|
Attendance at Other Treatment and Mutual-Help Groups
Time Frame: Change across the 12-month follow-up
|
Attendance at other treatment and mutual-help groups will be assessed at each time point using single, dichotomous (y/n) items on the Personal Information Questionnaire (PIQ).
These time-varying variables will be used as a secondary outcome and as a covariate of the treatment effects, as necessary.
|
Change across the 12-month follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Meaningful Activities Participation
Time Frame: Change across the 12-month follow-up
|
The Meaningful Activity Participation Assessment (MAPA) is a 28-item, psychometrically validated tool designed to measure level of engagement in general life activities that bring meaning to people's lives.
Respondents are presented with a list of various activities they may encounter in their day-to-day lives (e.g., socializing, writing, physical exercise, reading, prayer/meditation, community organization, computer use).
Each activity is then rated on 2, 4-point Likert scales assessing the frequency with which they engage in that activity and the level of meaningfulness ascribed to each.
The 2 scores for each item are combined multiplicatively, and a summary score, which reflects the overall level of engagement in meaningful activities, is formed.
The score range from 0 to 672 with a higher score indicating greater participation in meaningful activities.
The summary score will be used both as an outcome and as a potential mediator of the LEAP effect on alcohol and QoL outcomes.
|
Change across the 12-month follow-up
|
Site-Specific Activity Participation
Time Frame: Change across the 12-month follow-up
|
Site-specific activity participation will be measured using activity sign-up sheets across all 10 participating Housing First sites.
Site-specific activity sign-up sheets will document participants' engagement in all site-specific activities.
Level of engagement will be summed to form simple counts of activities in which each participant was involved over their 12-month assessment course.
Activities recorded will include but will not be limited to LEAP activities.
Higher scores indicate higher engagement in site-specific activities.
The summary score will be used both as an outcome and as a potential mediator of the LEAP effect on alcohol and QoL outcomes.
|
Change across the 12-month follow-up
|
Adult Resilience Measure-Revised (ARM-R)
Time Frame: Change across the 12-month follow-up
|
The ARM-R is a self-report measure that focuses on a relational understanding of well-being, framing resilience as an individual or community's ability to navigate to and negotiate for resources within their ecologies, while also acknowledging that it is up to the social-ecology to provide necessary resources in a way that individuals and communities value.
The ARM-R was adapted from the Child and Youth Resilience Measure (CYRM), which was developed as part of the International Resilience Project (IRP) at the Resilience Research Centre (RRC), involving 14 communities in 11 countries.
The ARM-R consists of 17 items and can be scored on 3 or 5 point Likert scales and 3 qualitative prompts.
|
Change across the 12-month follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Seema L Clifasefi, PhD MSW, University of Washington
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00007048
- 1R01AA026593-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Harm Reduction
-
National Cheng Kung UniversityHealing, Empowerment, Recovery of Chemsex (HERO) integrated care clinicEnrolling by invitation
-
University of PennsylvaniaCompleted
-
Rose Research Center, LLCFoundation for a Smoke Free World INCActive, not recruitingSmoking Cessation | Harm ReductionUnited States
-
Contract Research Organization el ABSwedish Match ABCompletedSmoking Cessation | Harm ReductionSweden
-
Rose Research Center, LLCFoundation for a Smoke-Free WorldCompletedSmoking Cessation | Harm ReductionUnited States
-
University of Colorado, DenverNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Not yet recruitingHarm Reduction | Medication AbuseUnited States
-
Rose Research Center, LLCFoundation for a Smoke Free World INCRecruitingSmoking Cessation | Harm ReductionUnited States
-
Far Eastern Memorial HospitalCompletedHarm Reduction | Adolescent BehaviorTaiwan
-
Contract Research Organization el ABSwedish Match ABCompletedSmoking Cessation | Harm Reduction | Smokeless TobaccoSweden
-
Contract Research Organization el ABSwedish Match ABCompletedSmoking Cessation | Harm Reduction | Smokeless TobaccoSweden
Clinical Trials on LEAP
-
Clinique Romande de ReadaptationCompletedStroke | Multiple Sclerosis | Cerebral Palsy | Parkinson Disease | Spinal Cord Injuries | People With Impaired Lower Extremity FunctionSwitzerland
-
University of Massachusetts, WorcesterNational Institute of Nursing Research (NINR)CompletedHepatitis cUnited States
-
Istanbul UniversityNot yet recruitingScleroderma, Systemic | Rehabilitation | Physiotherapy | Rheumatology | Hand Rheumatism | Video Games
-
VA Office of Research and DevelopmentActive, not recruitingSuicidal Self-directed Violence | Suicidal Preparatory BehaviorUnited States
-
University of Puget SoundCompleted
-
Cardiff UniversityCompletedMultiple SclerosisUnited Kingdom
-
Patricia SteeleUniversity of Calgary; Mount Royal University; Alberta Health Services, Calgary; SickKids Foundation and other collaboratorsCompleted
-
Universidad Rey Juan CarlosUnknownStroke | Brain Injuries, Traumatic | Treatment Adherence | Patient SatisfactionSpain
-
Seattle Children's HospitalNational Institutes of Health (NIH); National Center for Complementary and...CompletedAttention Deficit Hyperactivity DisorderUnited States